See more : Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Max India Limited (MAXIND.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Max India Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Acrinova AB (publ) (ACRI-B.ST) Income Statement Analysis – Financial Results
- Tai Ping Carpets International Limited (0146.HK) Income Statement Analysis – Financial Results
- CNC Holdings Limited (8356.HK) Income Statement Analysis – Financial Results
- Jia Group Holdings Limited (8519.HK) Income Statement Analysis – Financial Results
- Shinyei Kaisha (3004.T) Income Statement Analysis – Financial Results
Max India Limited (MAXIND.NS)
About Max India Limited
Max India Limited provides services related to senior living communities. It owns, develops, constructs, operates, and establishes residential communities for seniors. The company also offers daily living and memory care, home care, management and consultancy, and shared services, as well as medicare products. In addition, it is involved in the learning and development activities; and leasing of real estate properties. The company was formerly known as Advaita Allied Health Services Limited. Max India Limited was incorporated in 2019 and is based in Noida, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|---|
Revenue | 1.58B | 2.01B | 1.69B | 932.58M | 1.83B | 1.50B | 2.26B |
Cost of Revenue | 635.32M | 837.20M | 1.29B | 174.69M | 453.34M | 516.74M | 1.37B |
Gross Profit | 942.71M | 1.17B | 400.17M | 757.88M | 1.38B | 980.08M | 885.18M |
Gross Profit Ratio | 59.74% | 58.35% | 23.67% | 81.27% | 75.25% | 65.48% | 39.22% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 225.34M | 172.43M | 148.89M | 214.71M | 911.46M | 287.75M | 294.97M |
Selling & Marketing | 165.62M | 81.81M | 62.23M | 44.89M | 39.57M | 39.25M | 50.33M |
SG&A | 390.96M | 254.24M | 211.12M | 259.60M | 951.04M | 327.00M | 345.30M |
Other Expenses | 551.75M | 124.20M | 32.29M | 11.37M | 0.00 | 2.58M | 223.00K |
Operating Expenses | 942.71M | 1.25B | 1.10B | 1.38B | 951.04M | 1.43B | 1.41B |
Cost & Expenses | 1.58B | 2.09B | 2.39B | 1.55B | 1.40B | 1.95B | 2.79B |
Interest Income | 249.77M | 222.37M | 142.86M | 106.02M | 0.00 | 3.58M | 5.43M |
Interest Expense | 45.86M | 62.30M | 70.46M | 215.61M | 0.00 | 224.39M | 234.22M |
Depreciation & Amortization | 101.52M | 72.99M | 59.83M | 103.72M | 58.10M | 116.26M | 115.98M |
EBITDA | -376.40M | 116.60M | -38.89M | -300.30M | -35.34M | -146.14M | -245.53M |
EBITDA Ratio | -23.85% | 5.80% | -28.51% | -46.89% | -1.93% | -23.64% | -21.78% |
Operating Income | -641.96M | 32.10M | -102.30M | -541.00M | 426.97M | -470.15M | -607.69M |
Operating Income Ratio | -40.68% | 1.60% | -6.05% | -58.01% | 23.31% | -31.41% | -26.92% |
Total Other Income/Expenses | 151.61M | -66.63M | -231.11M | -107.31M | -1.18B | -634.25M | -67.05M |
Income Before Tax | -490.35M | -30.20M | -199.29M | -637.78M | -749.11M | -486.78M | -595.73M |
Income Before Tax Ratio | -31.07% | -1.50% | -11.79% | -68.39% | -40.90% | -32.52% | -26.39% |
Income Tax Expense | 73.42M | 73.80M | -18.93M | -106.61M | 44.73M | 25.40M | 72.44M |
Net Income | -563.77M | -104.00M | -180.36M | -531.16M | 2.55B | -862.65M | -423.84M |
Net Income Ratio | -35.73% | -5.17% | -10.67% | -56.96% | 139.03% | -57.63% | -18.78% |
EPS | -13.08 | -2.19 | -3.35 | -9.88 | 4.32 | -16.04 | -7.88 |
EPS Diluted | -13.08 | -2.18 | -3.34 | -9.88 | 47.34 | -16.04 | -7.88 |
Weighted Avg Shares Out | 43.11M | 47.57M | 53.79M | 53.79M | 589.25M | 53.79M | 53.79M |
Weighted Avg Shares Out (Dil) | 43.11M | 47.75M | 53.98M | 53.79M | 53.79M | 53.79M | 53.79M |
Source: https://incomestatements.info
Category: Stock Reports